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 Abstract 
 Background: Intraventricular hemorrhage (IVH) extension is common following acute intra-
cerebral hemorrhage (ICH) and is associated with poor prognosis.  Aim: To determine wheth-
er intensive blood pressure (BP)-lowering therapy reduces IVH growth.  Methods: Pooled 
analyses of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials
(INTERACT1 and INTERACT2) computed tomography (CT) substudies; multicenter, open, con-
trolled, randomized trials of patients with acute spontaneous ICH and elevated systolic BP, 
randomly assigned to intensive (<140 mm Hg) or guideline-based (<180 mm Hg) BP manage-
ment. Participants had blinded central analyses of baseline and 24-hour CT. Association of BP 
lowering to IVH growth was assessed in analysis of covariance.  Results: There was no signif-
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icant difference in adjusted mean IVH growth following intensive (n = 228) compared to 
guideline-recommended (n = 228) BP treatment (1.6 versus 2.2 ml, respectively; p = 0.56). 
Adjusted mean IVH growth was nonsignificantly greater in patients with a mean achieved 
systolic BP  ≥ 160 mm Hg over 24 h (3.94 ml; p trend = 0.26).  Conclusions: Early intensive BP-
lowering treatment had no clear effect on IVH in acute ICH.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Approximately one third of patients with acute spontaneous intracerebral hemorrhage 
(ICH) have intraventricular hemorrhage (IVH) extension, which confers a worse prognosis 
 [1] . High blood pressure (BP) is associated with both hematoma growth and poor outcome 
 [2] , but limited data exist on the relationship of BP and IVH  [3] . We aimed to determine 
whether BP-lowering therapy is associated with IVH growth among participants of the pilot 
and main phases of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage 
Trials (INTERACT1 and INTERACT2)  [2, 4] .
 Methods 
 The INTERACT studies were international, multicenter, prospective, open, blinded-
endpoint, randomized controlled trials, described in detail elsewhere  [2, 4] . They involved 
3,243 ICH patients (<6 h of onset; 404 INTERACT1, 2,839 INTERACT2) and elevated systolic 
BP (150–220 mm Hg) randomly assigned to intensive (target systolic BP <140 mm Hg) or 
guideline-recommended (<180 mm Hg) BP management. In predefined computed tomog-
raphy (CT) substudies, 1,310 consecutive patients (346 INTERACT1, 964 INTERACT2) had a 
second CT at 24 ± 3 h. ICH and IVH volume analyses were performed centrally by expert 
assessors blind to other data using MIStar version 3.2 (Apollo Medical Imaging Technology). 
The ethics committees approved the study protocols and written informed consent was 
obtained from the patients or appropriate surrogates.
 Absolute increase in IVH volume was log-transformed to remove skewness and to achieve 
near-normal distribution of data for analyses. The association of randomized BP-lowering 
treatment on the absolute increase in IVH volume over 24 h was assessed in analysis of cova-
riance (ANCOVA), adjusted for age, sex, baseline IVH volume, ICH location and volume, and 
China region. The mean achieved systolic BP over 24 h was calculated from the average of 1, 6, 
12, 18, and 24 h postrandomization readings; their association with absolute increase in IVH 
volume was assessed by ANCOVA adjusting for the same variables, and also for use of statin 
therapy, baseline systolic BP, and randomized treatment. A p value <0.05 was considered statis-
tically significant and SAS version 9.3 (SAS Institute, Cary, N.C., USA) was used in all analyses.
 Results 
 There were 456 CT substudy participants with IVH and available data (online suppl. 
fig. 1; for all online suppl. material, see www.karger.com/doi/10.1159/000448897). Guide-
line-treated patients were more likely to be female, but otherwise there were no significant 
differences in baseline characteristics, including time from onset to randomization, BP, as 
well as ICH and IVH volumes ( table 1 ).
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 No significant differences were observed in absolute or adjusted mean IVH growth 
between intensive and guideline BP-lowering treatment [3.4 (95% confidence interval 
1.2–5.5) vs. 4.8 ml (2.7–6.9), p = 0.35; 1.6 (0.2–3.1) vs. 2.2 (0.8–3.7), p = 0.56, respectively]. 
Patients with an achieved systolic BP over 24 h  ≥ 160 mm Hg were younger, more likely to be 
from China, and had a higher baseline BP (online suppl. table 1). There was a nonsignificant 
trend towards a greater absolute and adjusted mean IVH growth of 3.58 ml (1.56–5.72) and 
3.94 ml (1.46–6.61), respectively, with a mean achieved systolic BP over 24 h  ≥ 160 mm Hg 
( fig. 1 ). Patients with IVH growth were older, had higher National Institutes of Health Stroke 
Scale (NIHSS) scores, larger 24-hour ICH volumes, and smaller baseline IVH volumes (online 
suppl. table 2). The odds ratio for death or major disability was significantly greater with than 
without IVH growth (adjusted odds ratio 3.51, 95% confidence interval 2.05–6.02; online 
suppl. table 3).
 Table 1.  Characteristics of patients by randomized treatment
 Characteristic Intensive group
(n = 228)
Guideline group
(n = 228)
p 
value
Demographics
Age, years 67 (13) 68 (12) 0.28
Female 75 (33%) 97 (43%) 0.03
Chinese region 113 (50%) 112 (49%) 0.93
Medical history
Previous IVH 15 (7%) 17 (8%) 0.72
Previous ischemic stroke 23 (10%) 28 (12%) 0.47
Heart disease 10 (4%) 9 (4%) 0.81
Hypertension 161 (71%) 168 (74%) 0.51
Diabetes mellitus 32 (14%) 27 (12%) 0.47
Medication history
Antihypertensive agent 119 (52%) 118 (52%) 0.89
Oral anticoagulant 18 (8%) 14 (6%) 0.46
Antiplatelet therapy 38 (17%) 40 (18%) 0.80
Lipid-lowering therapy 27 (12%) 26 (11%) 0.87
Clinical features
Time from onset to randomization 3.7 (2.7 – 4.7) 3.5 (2.8 – 4.7) 0.89
Systolic BP 181 (17) 181 (17) 0.81
Diastolic BP 99 (15) 100 (15) 0.37
Glasgow Coma Scale score1 14 (12 – 15) 14 (12 – 15) 0.35
NIHSS score2 14 (9 – 18) 14 (9 – 19) 0.51
NIHSS score ≥15 102 (45%) 113 (50%) 0.28
CT findings
Time from onset to first CT, h 1.8 (1.3 – 2.6) 1.8 (1.2 – 2.5) 0.61
Baseline hematoma volume, ml 13.3 (7.5 – 27.5) 12.3 (7.3 – 25.7) 0.59
24-hour hematoma volume, ml 13.9 (7.8 – 34.0) 13.7 (8.0 – 40.2) 0.36
Baseline IVH volume 2.5 (0.2 – 9.6) 3.2 (0.0 – 12.6) 0.32
24-hour IVH volume 4.3 (1.5 – 12.5) 6.4 (1.6 – 15.3) 0.15
Baseline deep location of hematoma 186 (82%) 199 (87%) 0.09
Baseline intraventricular hematoma extension 178 (78%) 171 (75%) 0.44
 Data are n (%), mean ± SD, or median (IQR).
1 Scores on the Glasgow Coma Scale range from 15 (fully conscious) to 3 (deep coma). 2 Scores on the 
NIHSS range from 0 (normal neurologic status) to 42 (coma with quadriplegia).
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 Discussion 
 This post hoc analysis of 456 IVH patients from the INTERACT CT substudies showed no 
clear relationship between IVH growth in acute ICH and a strategy of early intensive BP 
management, supporting an earlier analysis of the INTERACT2 study of no association of BP 
and IVH volume  [1] . Thus, the clinical benefits of intensive BP lowering on functional outcome 
seen in the INTERACT studies are likely attributable to mechanisms other than IVH expansion.
 These results concur with a previous small prospective cohort study, where again no 
significant difference in admission systolic BP or mean BP across categories of IVH volumes 
within the first 24 h of ICH onset was reported  [5] . However, the mean 24-hour IVH volume 
was still higher in our standard BP treatment group, though not significantly different from 
intensive BP lowering. BP should not be excluded as a contributing factor to IVH growth. 
Whilst baseline BP per se does not appear to be a major factor in the pathogenesis of IVH, 
there was a trend towards a greater IVH volume growth at higher average achieved systolic 
BP over the first 24 h. Indeed, further analyses of the INTERACT2 study showed that rapid 
and sustained systolic BP reduction was associated with less ICH hematoma growth over
24 h  [6] . Another consideration relates to whether intensive BP reduction is associated with 
a lower risk of developing IVH. We previously reported that delayed IVH is associated with a 
worse prognosis, though neither intensive BP lowering nor deep location of ICH were signif-
icantly associated with delayed IVH  [7] .
 Whilst the strengths to this study include having a robust, well-characterized cohort from 
large international trials with standardized care, there are several limitations that include the 
exclusion of patients with large ICH volumes and impaired Glasgow Coma Scale, which makes 
the results less generalizable to more severe ICH. Furthermore, despite the large sample size, 
it is still too small to provide precise estimates of a modest effect of early intensive BP lowering 
on IVH.
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 Fig. 1. Intraventricular volume growth by average achieved BP between 1 and 24 h after randomization.
 † Assessed by ANCOVA adjusting for age, sex, China region, use of statin, baseline systolic BP, randomized 
treatment, baseline IVH volume, and ICH location. Because of skewed raw data, adjusted means are reported 
with 95% confidence intervals obtained by back-transformation. 
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 In summary, early intensive BP lowering according to the INTERACT protocol had no 
clear effect on IVH growth, although the lowest IVH growth was achieved in patients with 
sustained BP control over 24 h.
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